Hybrid Conferencee

International Conference on Neurodegenerative Diseases and Therapeutics (ICNDDT - 27)

2nd - 3rd March 2027 | Berlin, Germany
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Programme

Tentative Conference Agenda

Explore the proposed two-day programme developed around the conference Session Tracks and aligned United Nations Sustainable Development Goals.

Conference Format Hybrid Conference In-person and virtual participation
Programme 2 Days 2–3 March 2027
Academic Scope 11 Tracks Conference Session Tracks
Research Scope 20 Areas Call for Papers themes
SDG Alignment 5 SDGs SDGs 3, 4, 9, 10 and 16
Tentative Agenda & Timings

Session timings, sequence, track grouping and allocations are tentative and subject to change. Final timings will be confirmed closer to the conference. All timings follow the local time of the conference location.

Day 01

Opening, Keynote & Technical Sessions

2 MAR 2027 HYBRID
  1. 09:00 AM 09:30 AM

    Registration, Welcome Kit Collection & Virtual Check-in

    Participant arrival, credential verification and virtual lobby access.

    HYBRID
  2. 09:30 AM 09:45 AM

    Networking Tea & Digital Welcome

    Informal networking for on-site and virtual participants.

    HYBRID
  3. 09:45 AM 10:30 AM

    Welcome Address, Opening Plenary & Keynote Presentation I

    Opening of the conference and introduction to its research focus.

    PLENARY
  4. 10:30 AM 12:30 PM

    Concurrent Technical Session I

    3 TRACKS
    Track 01
    Pathophysiology of Neurodegenerative Diseases
    34
    Track Overview

    This session will explore the underlying biological mechanisms that contribute to neurodegenerative diseases. Emphasis will be placed on recent discoveries in cellular and molecular pathways involved in conditions such as Alzheimer's and Parkinson's.

    Track 02
    Innovative Therapeutic Approaches
    39
    Track Overview

    This track will focus on novel therapeutic strategies for managing neurodegenerative diseases. Presentations will cover cutting-edge research in drug development, gene therapy, and personalized medicine.

    Track 03
    Neuroinflammation and Neurodegeneration
    34
    Track Overview

    This session will examine the role of neuroinflammation in the progression of neurodegenerative diseases. Discussions will highlight the interplay between immune responses and neuronal health.

  5. 12:30 PM 01:30 PM

    Lunch & Networking Break

    Refreshment interval and networking opportunity.

    BREAK
  6. 01:30 PM 03:30 PM

    Concurrent Technical Session II

    3 TRACKS
    Track 04
    Cognitive Impairment in Neurodegenerative Disorders
    34
    Track Overview

    This track will delve into the cognitive deficits associated with various neurodegenerative diseases. Research findings on assessment tools and interventions aimed at improving cognitive function will be presented.

    Track 05
    Biomarkers for Early Diagnosis
    39
    Track Overview

    This session will focus on the identification and validation of biomarkers for early detection of neurodegenerative diseases. The importance of biomarkers in clinical trials and patient management will also be discussed.

    Track 06
    Neuroprotective Strategies
    34
    Track Overview

    This track will explore strategies aimed at protecting neuronal cells from degeneration. Topics will include pharmacological agents, lifestyle interventions, and their implications for patient care.

  7. 03:30 PM 04:00 PM

    Interactive Q&A, Day 1 Summary & Group Photo

    Closing interaction and key takeaways from the first day.

    CLOSING
View Day 02 Schedule →
Day 02

Keynote, Technical Sessions & Awards

3 MAR 2027 HYBRID
  1. 09:00 AM 09:15 AM

    Participant Check-in & Day 2 Welcome

    On-site attendance confirmation and virtual lobby access.

    HYBRID
  2. 09:15 AM 10:00 AM

    Keynote Presentation II

    Expert address on the future of the conference research domain.

    PLENARY
  3. 10:00 AM 12:00 PM

    Concurrent Technical Session III

    3 TRACKS
    Track 07
    Patient-Centered Approaches in Neurology
    310
    Track Overview

    This session will emphasize the importance of patient-centered care in the management of neurodegenerative diseases. Discussions will include the integration of patient preferences and experiences into therapeutic decision-making.

    Track 08
    Advancements in Neuroimaging Techniques
    39
    Track Overview

    This track will highlight the latest advancements in neuroimaging technologies for studying neurodegenerative diseases. Presentations will focus on how these techniques enhance our understanding of disease progression and treatment efficacy.

    Track 09
    Genetic and Environmental Risk Factors
    39
    Track Overview

    This session will investigate the genetic and environmental factors contributing to the risk of developing neurodegenerative diseases. The interplay between genetic predisposition and lifestyle choices will be a key focus.

  4. 12:00 PM 01:00 PM

    Lunch & Networking Break

    Refreshment interval and professional networking.

    BREAK
  5. 01:00 PM 03:00 PM

    Concurrent Technical Session IV

    2 TRACKS
    Track 10
    Ethical Considerations in Neurodegenerative Research
    316
    Track Overview

    This track will address the ethical challenges associated with research in neurodegenerative diseases. Discussions will include informed consent, patient autonomy, and the implications of emerging therapies.

    Track 11
    Future Directions in Neurodegenerative Disease Research
    39
    Track Overview

    This session will explore future research directions and emerging trends in the field of neurodegenerative diseases. Participants will discuss potential breakthroughs and the impact of interdisciplinary approaches on therapeutic development.

  6. 03:00 PM 03:30 PM

    Publications, Best Paper & Best Presentation Awards

    Publication guidance and recognition of outstanding research contributions.

    AWARDS
  7. 03:30 PM 04:00 PM

    Valedictory Session, Closing Remarks & Group Photo

    Conference summary, acknowledgements and formal conclusion.

    CLOSING
← Back to Day 01 Schedule
Aligned SDGs
3 Good Health and Well-being 4 Quality Education 9 Industry, Innovation and Infrastructure 10 Reduced Inequalities 16 Peace, Justice and Strong Institutions

Be Part of ICNDDT-27

Submit your research or complete your conference registration.

Submit Abstract / Paper Complete Registration
Copyrights © . All Rights Reserved. Terms & Conditions